Pharma IQ Glossary: ELISA (Enzyme Linked Immunosorbent Assay)
Enzyme Linked Immunosorbent Assay (ELISA) is defined as an assay that relies on an enzymatic conversion reaction and is used to detect the presence of specific substances (such as enzymes or viruses or antibodies or bacteria). During the procedure the test material or sample is exposed to a complex of an enzyme linked to an antibody specific to the disease or substance being tested for; when the enzyme and the antigen-antibody complex bind, a color indicator or other easily recognizable sign occurs.
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
April 19 by Pharmaceuticals & Biotechnology EditorThis video presentation demonstrates how hESC derived cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas describes how hESC derived Cytiva Card...
FDA to Address Industry Questions about Biosimilar Regulations at the Pharma's IQ Immunogenicity Event
April 04 by Pharma IQ NewsThis May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ's Immunogenicity event to discuss FDA directives on Immu...
Success and Accuracy in Genotoxicity and Carcinogenicity Testing: An FDA Perspective
September 21 by Pharma IQDr. Timothy Robison, Pharmacology/Toxicology Reviewer at the US Food and Drug Administration/CDER, joins Helen Winsor from Pharma IQ, to share the latest insights into achieving successful characteris...
